National Research (NRC) Competitors

OmniAb (NASDAQ:OABI) and National Research (NASDAQ:NRC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, community ranking, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

Does the MarketBeat Community favor OABI or NRC?

National Research received 93 more outperform votes than OmniAb when rated by MarketBeat users. However, 100.00% of users gave OmniAb an outperform vote while only 61.67% of users gave National Research an outperform vote.

Company	Underperform	Outperform
OmniAb	Outperform Votes 18 100.00%	Underperform Votes No Votes
National Research	Outperform Votes 111 61.67%	Underperform Votes 69 38.33%

Do insiders & institutionals believe in OABI or NRC?

72.1% of OmniAb shares are held by institutional investors. Comparatively, 47.3% of National Research shares are held by institutional investors. 8.6% of OmniAb shares are held by company insiders. Comparatively, 2.0% of National Research shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is OABI or NRC more profitable?

National Research has a net margin of 20.60% compared to National Research's net margin of -301.62%. OmniAb's return on equity of 54.83% beat National Research's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OmniAb	-301.62%	-19.93%	-16.65%
National Research	20.60%	54.83%	24.43%

Which has higher valuation & earnings, OABI or NRC?

National Research has higher revenue and earnings than OmniAb. OmniAb is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniAb	$21.05M	24.25	-$50.62M	-$0.64	-6.78
National Research	$148.58M	4.51	$30.97M	$1.24	22.65

Which has more risk & volatility, OABI or NRC?

OmniAb has a beta of -0.08, meaning that its stock price is 108% less volatile than the S&P 500. Comparatively, National Research has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500.

Does the media prefer OABI or NRC?

In the previous week, OmniAb had 4 more articles in the media than National Research. MarketBeat recorded 6 mentions for OmniAb and 2 mentions for National Research. National Research's average media sentiment score of 1.36 beat OmniAb's score of 0.32 indicating that OmniAb is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OmniAb	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
National Research	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts prefer OABI or NRC?

OmniAb currently has a consensus price target of $9.00, indicating a potential upside of 107.37%. Given National Research's higher probable upside, equities analysts clearly believe OmniAb is more favorable than National Research.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OmniAb	0 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	3.00
National Research	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

National Research beats OmniAb on 9 of the 17 factors compared between the two stocks.